Opinion The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs

Opinion: The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs

The FDA will carry on the policies that Scott Gottlieb worked on and promoted after he steps down as commissioner, says a former agency associate commissioner and longtime FDA watcher.

More From BioPortfolio on "Opinion: The policy initiatives Scott Gottlieb championed at the FDA will remain after he departs"